Hodgkin lymphoma (HL) is characterized by a rare multinucleated giant neoplastic cell in
tumors largely composed of other nonmalignant immune cells. It is clear that this entity …

Hodgkin lymphoma (HL) is a lymphatic malignancy with an estimated annual incidence of
80,000 cases world-wide. Modern therapy promises 5-year survival rates exceeding 90% for …

In the past decade there have been many advances in our understanding of Hodgkin's
disease. Among the most important is the discovery that the Reed–Sternberg cell is a …

Highlights•EBV-negative cases of CHL are characterized by increased karyotypic
complexity.•Cytogenetic features associated with CHL histologic subtype are also …

Hodgkin lymphoma (HL) has unique epidemiologic characteristics. The variation in
incidence according to age, sex, race, socioeconomic status, and histologic subtype …

Hodgkin lymphoma (HL) exists in two major forms, the so-called classical type (cHL) and the
nodular lymphocyte predominant type (NLPHL). Since NLPHL is considered to be an EBV …

Despite its well known histological and clinical features, Hodgkin's lymphoma (HL) has
recently been the object of intense research activity, leading to a better understanding of its …

Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has
recently been the object of intense research activity, leading to a better understanding of its …

Up to 40% of Hodgkin lymphoma (HL) cases are associated with the Epstein-Barr virus
(EBV). Clonal viral genomes can be found in the HL tumor cells, the Hodgkin Reed …

The pathogenesis of classical Hodgkin lymphoma (cHL) involves environmental and genetic
factors. To explore the role of the human leukocyte antigen (HLA) genes, we performed a …